DHR saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In 56 of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at 63%.
The Moving Average Convergence Divergence (MACD) for DHR just turned positive on October 14, 2026. Looking at past instances where DHR's MACD turned positive, the stock continued to rise in 26 of 47 cases over the following month. The odds of a continued upward trend are 55%.
DHR moved above its 50-day moving average on September 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for DHR moved above the 200-day moving average on September 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where DHR advanced for three days, in 174 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The 10-day RSI Indicator for DHR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 13 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
DHR broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DHR entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.062) is normal, around the industry mean (63.879). P/E Ratio (40.610) is within average values for comparable stocks, (1.769). Projected Growth (PEG Ratio) (1.361) is also within normal values, averaging (3.473). Dividend Yield (0.007) settles around the average of (0.002) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 26 (best 1 - 100 worst), indicating outstanding price growth. DHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
FFA saw its Momentum Indicator move below the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In 60 of the 76 cases, the stock moved further down in the following days. The odds of a decline are at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 70 cases where FFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
FFA moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for FFA crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
FFA broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for FFA entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Moving Average Convergence Divergence (MACD) for FFA just turned positive on October 07, 2026. Looking at past instances where FFA's MACD turned positive, the stock continued to rise in 46 of 54 cases over the following month. The odds of a continued upward trend are 85%.
Following a +1.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where FFA advanced for three days, in 286 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
DHR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 26 | |
P/E GROWTH RATING 1..100 | 53 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DHR | FFA | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 45% | N/A |
| Stochastic ODDS (%) | 4 days ago 61% | 4 days ago 73% |
| Momentum ODDS (%) | 4 days ago 63% | 4 days ago 79% |
| MACD ODDS (%) | 4 days ago 55% | 4 days ago 85% |
| TrendWeek ODDS (%) | 4 days ago 57% | 4 days ago 76% |
| TrendMonth ODDS (%) | 4 days ago 57% | 4 days ago 80% |
| Advances ODDS (%) | 5 days ago 55% | 8 days ago 82% |
| Declines ODDS (%) | 19 days ago 60% | 6 days ago 73% |
| BollingerBands ODDS (%) | 4 days ago 67% | 4 days ago 79% |
| Aroon ODDS (%) | 4 days ago 63% | 4 days ago 75% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 2 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 5 TA indicator(s) are bullish.
DHR (@Medical Specialties) experienced а +1.46% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.01%. For the same industry, the average monthly price growth was -7.30%, and the average quarterly price growth was +34.04%.
DHR is expected to report earnings on Oct 21, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
A.I.dvisor tells us that FFA and DHR have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FFA and DHR's prices will move in lockstep.
| Ticker / NAME | Correlation To FFA | 1D Price Change % | ||
|---|---|---|---|---|
| FFA | 100% | +0.09% | ||
| DHR - FFA | 9% Poorly correlated | -2.01% | ||
| JPM - FFA | 7% Poorly correlated | -1.82% | ||
| AAPL - FFA | 5% Poorly correlated | -0.15% | ||
| MSFT - FFA | 5% Poorly correlated | +0.84% | ||
| UNH - FFA | 1% Poorly correlated | +1.36% | ||
More | ||||